Comment on CMS-2026-1255-0001
athenahealthSupportBusiness
Summary: athenahealth, a healthcare technology company, supports the proposed rule to expand prior authorization API frameworks to include drugs, improve transparency in denial reasons, and adopt FHIR standards. However, the company requests a delayed implementation date to January 1, 2029, to allow stakeholders sufficient time to assess and build upon existing infrastructure.
athenahealth, Inc. ("athenahealth") appreciates the opportunity to respond to CMS-0062-P, the proposed rule addressing Interoperability Standards and Prior Authorization for Drugs across Medicare Advantage, Medicaid managed care, CHIP, and Qualified Health Plans on the Federally-Facilitated Exchanges. Please see our attached comments.
Thank you,.
Jennifer Michaels
athenahealth